OR WAIT 15 SECS
April 24, 2019
Article
DUAKLIR PRESSAIR (aclidinium bromide and formoterol fumarate) provides LAMA/LABA therapy.
April 17, 2019
Approved regulations allow for some flexibility for drugs that can be redistributed or qualify for manufacturer credit.
April 12, 2019
Erdafitinib is first targeted therapy for FGFR3 or FGFR2 genetic alteration.
December 17, 2018
Health systems employ Artifical Intelligence and integrated medication management to address diversion.